AlMutawah Abdullah A, Kim Taegyeong, Chung Jong Woo
Department of Otorhinolaryngology-Head and Neck Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Republic of Korea.
Department of Otorhinolaryngology-Head and Neck Surgery, Jahra Hospital, Ministry of Health, Jahra 00043, Kuwait.
J Clin Med. 2024 May 22;13(11):3042. doi: 10.3390/jcm13113042.
: Simultaneous removal and cochlear implantation (CI) have been reported in intralabyrinthine and intracochlear schwannoma. A wide range of postoperative hearing outcomes have been reported after CI in these cases. This study evaluated the outcomes of performing a simultaneous resection of Schwannoma in cochlea and cochlear implantation (CI), aiming to assess the effectiveness of this combined surgical approach for hearing rehabilitation with CI. : This retrospective case series was conducted at a tertiary care center. The study included four consecutive patients with profound sensorineural hearing loss due to a mass inside the cochlea. These patients underwent simultaneous single-sided CI and tumor resection performed by the same surgeon. Preoperative and postoperative audiological assessments were conducted to evaluate the patients' hearing outcomes before and after the surgical intervention. : Simultaneous CI with tumor resection was successful in all cases. Two of the four patients had a unilateral tumor, while the other two had a bilateral tumor with the involvement of the internal auditory canal and cerebellopontine angle (neurofibromatosis type 2 (NF2)). In two cases of unilateral tumor, aided free-field pure tone average (PTA) was 26 dB, and 46 dB hearing level (HL), and word recognition score (WRS) at 65 dB was 40% and 68%, respectively, 3 months after surgery. In two cases of tumor with NF2, aided free-field PTA was 36 dB and 60 dB HL, and both cases showed 0% WRS at 65 dB 3 months after surgery. : Simultaneous schwannoma excision and CI in patients with Schwannoma inside cochlea are surgically practical and safe. Postoperatively, there was a notable improvement in hearing in cases of sporadic schwannoma, regardless of the type of CI used. However, there was 0% WRS in the two NF2 patients with a mass in the internal auditory canal.
: 据报道,在迷路内和耳蜗内神经鞘瘤中可同时进行肿瘤切除和人工耳蜗植入(CI)。这些病例中,CI术后的听力结果范围广泛。本研究评估了同时切除耳蜗神经鞘瘤和人工耳蜗植入(CI)的结果,旨在评估这种联合手术方法对CI听力康复的有效性。: 本回顾性病例系列研究在一家三级医疗中心进行。该研究纳入了4例因耳蜗内肿物导致重度感音神经性听力损失的连续患者。这些患者由同一位外科医生同时进行了单侧CI和肿瘤切除。术前和术后进行了听力学评估,以评估手术干预前后患者的听力结果。: 所有病例中同时进行CI和肿瘤切除均成功。4例患者中有2例为单侧肿瘤,另外2例为双侧肿瘤,累及内耳道和桥小脑角(2型神经纤维瘤病(NF2))。在2例单侧肿瘤病例中,术后3个月时,助听自由声场纯音平均听阈(PTA)分别为26 dB和46 dB听力级(HL),65 dB时的言语识别得分(WRS)分别为40%和68%。在2例NF2肿瘤病例中,助听自由声场PTA分别为36 dB和60 dB HL,术后3个月时,2例患者在65 dB时的WRS均为0%。: 对于耳蜗内有神经鞘瘤的患者,同时切除神经鞘瘤和CI在手术上是可行且安全的。术后,散发性神经鞘瘤病例的听力有显著改善,无论使用何种类型的CI。然而,2例内耳道有肿物的NF2患者的WRS为0%。